Process and system for obtaining botulinum neurotoxin

Details for Australian Patent Application No. 2010273601 (hide)

Owner Allergan, Inc.

Inventors Ton, Jennifer L.; Patel, Hemant A.; Bates, Ronald C.; Ahmad, Wajdie M.

Agent Davies Collison Cave

Pub. Number AU-A-2010273601

PCT Pub. Number WO2011/008713

Priority 12/502,181 13.07.09 US

Filing date 12 July 2010

Wipo publication date 20 January 2011

International Classifications

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/008713 Priority application(s): WO2011/008713

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010273611-Tube with reverse necking properties

2010273597-Apoptosis signal-regulating kinase inhibitors